Capsule Endoscopy in Obscure GI Bleeding
Launched by UNIVERSITY OF CALGARY · Sep 13, 2005
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
The purpose of this study is to conduct a cost-effectiveness analysis of wireless capsule endoscopy in the investigation of patients with overt obscure gastrointestinal bleeding. To inform this analysis, a randomized controlled trial of capsule endoscopy compared with standard care will be conducted. Patients randomized 1:1.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 18 or older
- • 2. Obscure overt GI bleeding
- • 3. No cause for bleeding found on Gastroscopy and colonoscopy within 1 week of bleeding
- Exclusion Criteria:
- • 1. Known or suspected swallowing disorders
- • 2. Known or suspected small bowel obstruction
- • 3. Multiple comorbidities precluding surgery
- • 4. Patients with implantable electromagnetic devices
- • 5. Pregnant women
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Trial Officials
Robert J Hilsden, MD PhD
Principal Investigator
University of Calgary
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials